Optimizing an immunomodulatory potency assay for Mesenchymal Stromal Cell

The expeditious progress of Mesenchymal Stromal Cells (MSC) for therapeutic intervention calls for means to compare differences in potency of cell products. The differences may be attributed to innumerable sources including tissue origin, production methods, or even between batches. While the immuno...

Full description

Bibliographic Details
Main Authors: Stine Bangsgaard Hansen, Lisbeth Drozd Højgaard, Jens Kastrup, Annette Ekblond, Bjarke Follin, Morten Juhl
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1085312/full